Table 4.
The pathogen related mortality and the ratio of inadequate antibiotics
| |
Mortality |
Initial inappropriate antibiotic use |
Association of mortality and initial inappropriate antibiotic use |
|---|---|---|---|
| N (%) | N (%) | ( P value) | |
|
Gram(+) bacteria
|
|
|
|
|
Staphylococcus aureus |
21/38 (55.3%) |
25/38 (65.8%) |
0.011 |
| MSSA |
1/7 (14.3%) |
0/7 (0.0%) |
- |
| MRSA |
20/31 (64.5%) |
25/31 (80.6%) |
0.151 |
|
Coagulase-negative Staphylococcus |
3/5 (60.0%) |
3/5 (60.0%) |
1.000 |
|
Beta-hemolytic Streptococcus (Non Group A or B) |
0/1 (0.0%) |
0/1 (0.0%) |
- |
|
Streptococcus pneumoniae |
2/2 (100.0%) |
0/2 (0.0%) |
- |
|
Viridans Streptococcus |
2/3 (66.7%) |
0/3 (0.0%) |
- |
|
Enterococcus faecalis |
5/10 (50.0%) |
9/10 (90.0%) |
1.000 |
|
Corynebacterium spp. |
0/7 (0.0%) |
3/7 (42.9%) |
- |
|
Enterobacteriaceae
|
|
|
|
|
Escherichia coli |
16/42 (38.1%) |
21/42 (50.0%) |
0.340 |
|
Klebsiella pneumoniae |
21/34 (61.8%) |
23/34 (67.6%) |
1.000 |
|
Proteus mirabilis |
4/10 (40.0%) |
6/10 (60.0%) |
1.000 |
|
Enterobacter cloacae |
0/1 (0.0%) |
1/1 (100.0%) |
- |
|
Enterobacter aerogenes |
3/6 (50.0%) |
4/6 (66.7%) |
0.400 |
|
Serratia marcescens |
2/4 (50.0%) |
3/4 (75.0%) |
1.000 |
|
Non-typhoidal Salmonella |
1/4 (25.0%) |
2/4 (50.0%) |
1.000 |
|
Providencia rettgeri |
1/3 (33.3%) |
2/3 (66.7%) |
0.333 |
|
Morganella morganii |
0/3 (0.0%) |
1/3 (33.3%) |
- |
|
Citrobacter spp. |
1/1 (100.0%) |
1/1 (100.0%) |
- |
|
Haemophilus influenzae |
1/1 (100.0%) |
1/1 (100.0%) |
- |
|
Glucose Non-fermenter
|
|
|
|
|
Pseudomonas aeruginosa |
4/7 (57.1%) |
5/7 (71.4%) |
1.000 |
|
Burkholderia cepacia |
8/23 (34.8%) |
12/23 (52.2%) |
0.193 |
|
Acinetobacter baumannii |
6/8 (75.0%) |
5/8 (62.5%) |
1.000 |
|
Stenotrophomonas maltophilia |
1/1 (100.0%) |
0/1 (0.0%) |
- |
|
Anaerobes
|
|
|
|
|
Peptostreptococcus spp. |
0/2 (0.0%) |
1/2 (50.0%) |
- |
|
Propionibacterium spp. |
0/4 (0.0%) |
2/4 (50.0%) |
- |
| Candida spp | 2/2 (100.0%) | 1/2 (50.0%) | - |
MRSA Methicillin resistant Staphylococcus aureus, MSSA Methicillin susceptible Staphylococcus aureus.